MAVIRET is a prescription medication used in the treatment of chronic hepatitis C virus (HCV) infection in adults. It is a combination of two antiviral drugs, glecaprevir and pibrentasvir, which work together to inhibit the replication of the hepatitis C virus within the body. MAVIRET is taken in the form of oral tablets and is notable for its broad efficacy across various genotypes of the virus, offering a cure for many patients with a short treatment duration, typically 8 to 12 weeks. This medication is generally well-tolerated, with a low rate of serious side effects. However, it is important for patients to discuss their full medical history and current medications with their healthcare provider before starting treatment with MAVIRET to avoid potential drug interactions and contraindications.